Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Arrhythmias

  Free Subscription


Articles published in Circulation

Retrieve available abstracts of 221 articles:
HTML format



Single Articles


    February 2024
  1. LIN AE, Bapat AC, Xiao L, Niroula A, et al
    Clonal Hematopoiesis of Indeterminate Potential With Loss of Tet2 Enhances Risk for Atrial Fibrillation Through Nlrp3 Inflammasome Activation.
    Circulation. 2024 Feb 15. doi: 10.1161/CIRCULATIONAHA.123.065597.
    PubMed     Abstract available


  2. SANCHEZ RH, Hamdan H, Torrealba J, Grodin JL, et al
    Giants Hiding in Small Places: A Case of New Onset Heart Failure, Atrioventricular Block, and Ventricular Arrhythmias.
    Circulation. 2024;149:475-480.
    PubMed    


  3. GALEA R, Meneveau N, De Marco F, Aminian A, et al
    One-Year Outcomes After Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: A Prespecified Analysis of the SWISS-APERO Randomized Clinical Trial.
    Circulation. 2024;149:484-486.
    PubMed    


    January 2024
  4. LEE SY, Lee BK
    Palpitations and Recurrent Syncope in a Young Woman.
    Circulation. 2024;149:402-405.
    PubMed    


  5. HERWEG B, Sharma PS, Cano O, Ponnusamy SS, et al
    Arrhythmic Risk in Biventricular Pacing Compared With Left Bundle Branch Area Pacing: Results From the I-CLAS Study.
    Circulation. 2024;149:379-390.
    PubMed     Abstract available


  6. PATEL SM, Braunwald E, Steffel J, Boriani G, et al
    Efficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of Four Randomized Clinical Trials of 58 464 Patients With Atrial Fibr
    Circulation. 2024 Jan 24. doi: 10.1161/CIRCULATIONAHA.123.066279.
    PubMed     Abstract available


  7. WALLENTIN L, Giugliano RP
    Switching to Direct Anticoagulation or Continued Vitamin-K Antagonists in Frail Patients With Atrial Fibrillation in Whom Vitamin-K Antagonists Are Tolerated?
    Circulation. 2024;149:290-292.
    PubMed    


  8. BROMAN MT, Nadadur RD, Perez-Cervantes C, Burnicka-Turek O, et al
    A Genomic Link From Heart Failure to Atrial Fibrillation Risk: FOG2 Modulates a TBX5/GATA4-Dependent Atrial Gene Regulatory Network.
    Circulation. 2024 Jan 8. doi: 10.1161/CIRCULATIONAHA.123.066804.
    PubMed     Abstract available



  9. Correction to: 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2024;149:e167.
    PubMed    


    December 2023
  10. OSTERGAARD L, Olesen JB, Petersen JK, Nielsen LS, et al
    Arterial Thromboembolism in Patients With Atrial Fibrillation and CHA(2)DS(2)-VASc 1: A Nationwide Study.
    Circulation. 2023 Dec 28. doi: 10.1161/CIRCULATIONAHA.123.066477.
    PubMed     Abstract available


  11. BERGEMAN AT, Lieve KVV, Kallas D, Bos JM, et al
    Flecainide Is Associated With a Lower Incidence of Arrhythmic Events in a Large Cohort of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia.
    Circulation. 2023;148:2029-2037.
    PubMed     Abstract available


  12. VAN DUIJVENBODEN S, Ramirez J, Orini M, Aung N, et al
    Prognostic Significance of Different Ventricular Ectopic Burdens During Submaximal Exercise in Asymptomatic UK Biobank Subjects.
    Circulation. 2023;148:1932-1944.
    PubMed     Abstract available


  13. KATAOKA N, Imamura T, Kinugawa K
    Letter by Kataoka et al Regarding Article, "Long-Term Outcomes of Brugada Substrate Ablation: A Report From BRAVO (Brugada Ablation of VF Substrate Ongoing Multicenter Registry)".
    Circulation. 2023;148:1914.
    PubMed    


    November 2023
  14. JOGLAR JA, Chung MK, Armbruster AL, Benjamin EJ, et al
    2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2023 Nov 30. doi: 10.1161/CIR.0000000000001193.
    PubMed     Abstract available


  15. KHIDHIR A, Curtis AB
    Perspective on ACC/AHA/ACCP/HRS Guidelines for the Management of Atrial Fibrillation.
    Circulation. 2023 Nov 30. doi: 10.1161/CIRCULATIONAHA.123.066919.
    PubMed    


  16. ROWIN EJ, Link MS, Maron MS, Maron BJ, et al
    Evolving Contemporary Management of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
    Circulation. 2023;148:1797-1811.
    PubMed     Abstract available


  17. HIGUCHI S, Voskoboinik A, Il Im S, Lee A, et al
    Frequent Premature Atrial Contractions Lead to Adverse Atrial Remodeling and Atrial Fibrillation in a Swine Model.
    Circulation. 2023 Nov 23. doi: 10.1161/CIRCULATIONAHA.123.065874.
    PubMed     Abstract available


  18. GONZALEZ-TORRECILLA E, Luna Lopez R, Avila Alonso P
    Atrioventricular Block: Does This Patient Require a Pacemaker?
    Circulation. 2023;148:1725-1727.
    PubMed    


  19. SEO K, Yamamoto Y, Kirillova A, Kawana M, et al
    Improved Cardiac Performance and Decreased Arrhythmia in Hypertrophic Cardiomyopathy With Non-beta-Blocking R-Enantiomer Carvedilol.
    Circulation. 2023;148:1691-1704.
    PubMed     Abstract available


  20. QI M, Ma S, Liu J, Liu X, et al
    In Vivo Base Editing of Scn5a Rescues Type 3 Long QT Syndrome in Mice.
    Circulation. 2023 Nov 15. doi: 10.1161/CIRCULATIONAHA.123.065624.
    PubMed     Abstract available


  21. WILDE AAM, Saenen J
    Risk Stratification in Brugada Syndrome: How Low Can We Go?
    Circulation. 2023;148:1556-1558.
    PubMed    


  22. BELBACHIR N, Wu Y, Shen M, Zhang SL, et al
    Studying Long QT Syndrome Caused by NAA10 Genetic Variants Using Patient-Derived Induced Pluripotent Stem Cells.
    Circulation. 2023;148:1598-1601.
    PubMed    


  23. KIM MC, Lim Y, Lee SH, Shin Y, et al
    Early Left Ventricular Unloading or Conventional Approach After Venoarterial Extracorporeal Membrane Oxygenation: The EARLY-UNLOAD Randomized Clinical Trial.
    Circulation. 2023;148:1570-1581.
    PubMed     Abstract available


  24. GAITA F, Cerrato N, Giustetto C, Martino A, et al
    Asymptomatic Patients With Brugada ECG Pattern: Long-Term Prognosis From a Large Prospective Study.
    Circulation. 2023;148:1543-1555.
    PubMed     Abstract available


  25. HOSOKAWA K, Watanabe H, Taniguchi Y, Ikeda N, et al
    A Multicenter, Single-Blind, Randomized, Warfarin-Controlled Trial of Edoxaban in Patients With Chronic Thromboembolic Pulmonary Hypertension: KABUKI Trial.
    Circulation. 2023 Nov 13. doi: 10.1161/CIRCULATIONAHA.123.067528.
    PubMed    


  26. MCINTYRE WF, Benz AP, Becher N, Healey JS, et al
    Direct Oral Anticoagulants for Stroke Prevention in Patients with Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials.
    Circulation. 2023 Nov 12. doi: 10.1161/CIRCULATIONAHA.123.067512.
    PubMed     Abstract available


  27. POKORNEY SD, Granger CB
    The Need for Randomized Trials to Define the Optimal Dose of Anticoagulants for Atrial Fibrillation in Chronic Kidney Disease.
    Circulation. 2023;148:1455-1458.
    PubMed    


    October 2023
  28. STEVENSON WG, Tandri H, Roden DM
    The Shape of Ventricular Tachycardia.
    Circulation. 2023;148:1368-1370.
    PubMed    


  29. NISHIMURA T, Shatz N, Weiss JP, Zawaneh M, et al
    Identification of Human Ventricular Tachycardia Demarcated by Fixed Lines of Conduction Block in a 3-Dimensional Hyperboloid Circuit.
    Circulation. 2023;148:1354-1367.
    PubMed     Abstract available


  30. KAPADIA SR, Krishnaswamy A, Whisenant B, Potluri S, et al
    Concomitant Left Atrial Appendage Occlusion and Transcatheter Aortic Valve Replacement Among Patients with Atrial Fibrillation.
    Circulation. 2023 Oct 24. doi: 10.1161/CIRCULATIONAHA.123.067312.
    PubMed     Abstract available


  31. O'HARA PE, Venkatesh V, Lehrenbaum H
    A Unique Case of Right Axis Deviation.
    Circulation. 2023;148:1261-1262.
    PubMed    


  32. KRISAI P, Kuhne M, Sticherling C
    Letter by Krisai et al Regarding Article, "Pulsed Field Ablation for the Treatment of Atrial Fibrillation: PULSED AF Pivotal Trial".
    Circulation. 2023;148:1182.
    PubMed    


  33. BUTT JH, Yafasova A, Doi SN, Nielsen JC, et al
    Implantable Cardioverter Defibrillator in Patients With Nonischemic Systolic Heart Failure With and Without Cardiac Resynchronization Therapy: Extended Follow-Up Study of the DANISH Trial.
    Circulation. 2023;148:1179-1181.
    PubMed    


    September 2023
  34. PARKASH R, O'Meara E, Tang ASL
    The Role of Ablation-Based Rhythm Control in the Tangled Web of Atrial Fibrillation and Heart Failure.
    Circulation. 2023;148:933-935.
    PubMed    


  35. EZEKOWITZ MD, Kamareddine M
    Filling an Important Knowledge Gap: The DOAC Score.
    Circulation. 2023;148:947-949.
    PubMed    


  36. PERERA D, Morgan HP, Ryan M, Dodd M, et al
    Arrhythmia and Death Following Percutaneous Revascularization in Ischemic Left Ventricular Dysfunction: Prespecified Analyses From the REVIVED-BCIS2 Trial.
    Circulation. 2023;148:862-871.
    PubMed     Abstract available


  37. XU Y, Chang AR, Inker LA, McAdams-DeMarco M, et al
    Associations of Apixaban Dose With Safety and Effectiveness Outcomes in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease.
    Circulation. 2023 Sep 8. doi: 10.1161/CIRCULATIONAHA.123.065614.
    PubMed     Abstract available


  38. PUNDI K, Marcus GM, Turakhia M
    The Epidemic and Data-Free Zone of Nonsustained Ventricular Tachycardia: An Unintended Consequence of Digital Monitoring and a Path Forward.
    Circulation. 2023;148:805-807.
    PubMed    


  39. XIAO SY, Goldschlager N, Durstenfeld MS
    Chest Pain, Bundle Branch Block, and Wide Complex Tachycardia: Is Three a Company or Crowd?
    Circulation. 2023;148:845-847.
    PubMed    


    August 2023
  40. JOOSTEN LPT, van Doorn S, van de Ven PM, Kohlen BTG, et al
    Safety of Switching from a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients with Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial.
    Circulation. 2023 Aug 27. doi: 10.1161/CIRCULATIONAHA.123.066485.
    PubMed     Abstract available


  41. AGGARWAL R, Ruff CT, Virdone S, Perreault S, et al
    Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants.
    Circulation. 2023 Aug 25. doi: 10.1161/CIRCULATIONAHA.123.064556.
    PubMed    


  42. MUSTROPH J, Baier MJ, Unsin D, Provaznik Z, et al
    Ethanol-Induced Atrial Fibrillation Results From Late I(Na) and Can Be Prevented by Ranolazine.
    Circulation. 2023;148:698-700.
    PubMed    


  43. ALGALARRONDO V, Extramiana F
    Autoimmune Atrial Fibrillation or Atrial Fibrillation-Induced Autoimmunity? A New Atrial Fibrillation Begets Atrial Fibrillation Pathway?
    Circulation. 2023;148:499-501.
    PubMed    


  44. JIAO T, Ruzieh M
    Letter by Jiao and Ruzieh Regarding Article, "Comparative Effectiveness of Left Atrial Appendage Occlusion Versus Oral Anticoagulation by Sex".
    Circulation. 2023;148:508-509.
    PubMed    


  45. RAJJOUB K, Rajjoub EA, Ramos-Jimenez J
    What Is the Mechanism of the Premature Beats?
    Circulation. 2023;148:426-429.
    PubMed    


    July 2023
  46. VAZQUEZ E, Vazquez-Sanchez T, Sanchez-Perales C
    Letter by Vazquez et al Regarding Article, "Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial".
    Circulation. 2023;148:378.
    PubMed    


  47. YOUNIS A, Ali S, Hsich E, Goldenberg I, et al
    Arrhythmia and Survival Outcomes Among Black Patients and White Patients With a Primary Prevention Defibrillator.
    Circulation. 2023;148:241-252.
    PubMed     Abstract available


  48. AL-KHATIB SM, Thomas KL
    Advancing Equity in Sudden Cardiac Death Prevention: Beware of Making Assumptions About the Effectiveness of Primary Prevention Implantable Cardioverter-Defibrillators in Black Patients.
    Circulation. 2023;148:253-255.
    PubMed    


  49. HAISSAGUERRE M, Duchateau J, Laredo M, Lavergne T, et al
    Inducibility of Short-Coupled Purkinje Ectopy by Pharmacological Tests in Patients With Spontaneous Short-Coupled Idiopathic Ventricular Fibrillation.
    Circulation. 2023;148:70-72.
    PubMed    


  50. MAGUY A, Mahendran Y, Tardif JC, Busseuil D, et al
    Autoimmune Atrial Fibrillation.
    Circulation. 2023 Jul 4. doi: 10.1161/CIRCULATIONAHA.122.062776.
    PubMed     Abstract available


    June 2023
  51. HOCHSTADT A, Geist M, Viskin S
    Occam's Razor: Two Arrhythmias in a Single Heart?
    Circulation. 2023;147:1779-1781.
    PubMed    


  52. COULT J, Yang BY, Kwok H, Kutz JN, et al
    Prediction of Shock-Refractory Ventricular Fibrillation During Resuscitation of Out-of-Hospital Cardiac Arrest.
    Circulation. 2023 Jun 2. doi: 10.1161/CIRCULATIONAHA.122.063651.
    PubMed     Abstract available


    May 2023
  53. DOUNDOULAKIS I, Tsioufis K, Gatzoulis KA
    Letter by Doundoulakis et al Regarding Article, "Programmed Ventricular Stimulation as Additional Primary Prevention Risk Stratification Tool in Arrhythmogenic Right Ventricular Cardiomyopathy".
    Circulation. 2023;147:1714.
    PubMed    


  54. MILES C, Boukens BJ, Scrocco C, Wilde AAM, et al
    Subepicardial Cardiomyopathy: A Disease Underlying J-Wave Syndromes and Idiopathic Ventricular Fibrillation.
    Circulation. 2023;147:1622-1633.
    PubMed     Abstract available


  55. VISKIN S, Rosso R
    Treatment of Brugada Syndrome in 2023: Know Where You Come From to Know Where You Are Going.
    Circulation. 2023;147:1579-1581.
    PubMed    


  56. NADEMANEE K, Chung FP, Sacher F, Nogami A, et al
    Long-Term Outcomes of Brugada Substrate Ablation: A Report from BRAVO (Brugada Ablation of VF Substrate Ongoing Multicenter Registry).
    Circulation. 2023;147:1568-1578.
    PubMed     Abstract available


  57. TURAGAM MK, Neuzil P, Schmidt B, Reichlin T, et al
    Safety and Effectiveness of Pulsed Field Ablation to Treat Atrial Fibrillation: One-Year Outcomes From the MANIFEST-PF Registry.
    Circulation. 2023 May 18. doi: 10.1161/CIRCULATIONAHA.123.064959.
    PubMed     Abstract available


  58. RUSSO AM
    Pulsed Field Ablation: Is It Better Than Conventional Thermal Ablation for Treatment of Atrial Fibrillation?
    Circulation. 2023;147:1433-1435.
    PubMed    


  59. GUPTA AR, Deshmukh AJ, Del-Carpio Munoz F
    A Tale of Two Parallel Rhythms.
    Circulation. 2023;147:1463-1466.
    PubMed    


  60. DUAN H, Zhang CH
    A Series of Abnormal ECGs: Are They Benign or Sinister?
    Circulation. 2023;147:1407-1410.
    PubMed    


  61. WANG Y, Wang J, Shi L, Chen X, et al
    CIB2 Is a Novel Endogenous Repressor of Atrial Remodeling.
    Circulation. 2023 May 2. doi: 10.1161/CIRCULATIONAHA.122.062660.
    PubMed     Abstract available


    April 2023

  62. Correction to: Atrial Fibrillation Occurring During Acute Hospitalization: A Scientific Statement From the American Heart Association.
    Circulation. 2023;147:e717.
    PubMed    


  63. XING LY, Diederichsen SZ, Hojberg S, Krieger DW, et al
    Effects of Systematic Atrial Fibrillation Screening According to N-Terminal Pro-B-Type Natriuretic Peptide: a Secondary Analysis of the Randomized LOOP Study.
    Circulation. 2023 Apr 15. doi: 10.1161/CIRCULATIONAHA.123.064361.
    PubMed     Abstract available


  64. HARRINGTON J, Carnicelli AP, Hua K, Wallentin L, et al
    Direct Oral Anticoagulants Versus Warfarin Across the Spectrum of Kidney Function: Patient-Level Network Meta-Analyses From COMBINE AF.
    Circulation. 2023 Apr 12. doi: 10.1161/CIRCULATIONAHA.122.062752.
    PubMed     Abstract available


  65. KIM JU, Bray J, Ahmad M
    Letter by Kim et al Regarding Article, "Detection of Atrial Fibrillation in a Large Population Using Wearable Devices: The Fitbit Heart Study".
    Circulation. 2023;147:1186-1187.
    PubMed    


    March 2023
  66. BAPAT A, Schloss MJ, Yamazoe M, Grune J, et al
    A Mouse Model of Atrial Fibrillation in Sepsis.
    Circulation. 2023;147:1047-1049.
    PubMed    


  67. CHYOU JY, Barkoudah E, Dukes JW, Goldstein LB, et al
    Atrial Fibrillation Occurring During Acute Hospitalization: A Scientific Statement From the American Heart Association.
    Circulation. 2023 Mar 13. doi: 10.1161/CIR.0000000000001133.
    PubMed     Abstract available


  68. HYDES TJ, Lip GYH, Lane DA
    Use of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Liver Disease.
    Circulation. 2023;147:795-797.
    PubMed    


  69. FRIEDMAN DJ, Al-Khatib SM, Dalgaard F, Fudim M, et al
    Cardiac Resynchronization Therapy Improves Outcomes in Patients With Intraventricular Conduction Delay But Not Right Bundle Branch Block: A Patient-Level Meta-Analysis of Randomized Controlled Trials.
    Circulation. 2023;147:812-823.
    PubMed     Abstract available


  70. VERMA A, Haines DE, Boersma LV, Sood N, et al
    Pulsed Field Ablation for the Treatment of Atrial Fibrillation: PULSED AF Pivotal Trial.
    Circulation. 2023 Mar 6. doi: 10.1161/CIRCULATIONAHA.123.063988.
    PubMed     Abstract available


    February 2023
  71. CONWAY J, Min S, Villa C, Weintraub RG, et al
    The Prevalence and Association of Exercise Test Abnormalities With Sudden Cardiac Death and Transplant-Free Survival in Childhood Hypertrophic Cardiomyopathy.
    Circulation. 2023;147:718-727.
    PubMed     Abstract available


  72. ZEITLER EP, Kearing S, Coylewright M, Nair D, et al
    Comparative Effectiveness of Left Atrial Appendage Occlusion Versus Oral Anticoagulation by Sex.
    Circulation. 2023;147:586-596.
    PubMed     Abstract available


  73. LAWAL OD, Aronow HD, Shobayo F, Hume AL, et al
    Comparative Effectiveness and Safety of Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and Chronic Liver Disease: A Nationwide Cohort Study.
    Circulation. 2023 Feb 10. doi: 10.1161/CIRCULATIONAHA.122.060687.
    PubMed     Abstract available


    January 2023
  74. HIGASHIKUNI Y, Liu W, Numata G, Tanaka K, et al
    NLRP3 Inflammasome Activation Through Heart-Brain Interaction Initiates Cardiac Inflammation and Hypertrophy During Pressure Overload.
    Circulation. 2023;147:338-355.
    PubMed     Abstract available


  75. HAGHIGHAT L, Goldschlager N, Oesterle A
    ECG Challenge: AV Block or Something Else?
    Circulation. 2023;147:267-270.
    PubMed    


  76. YANG Z, Zhang CH, Li X
    What Is the Truth Behind Abnormal ECG Changes?
    Circulation. 2023;147:175-177.
    PubMed    


    December 2022
  77. WEITZ JI, Eikelboom JW
    What Is the Future of Factor XI Inhibitors?
    Circulation. 2022;146:1899-1902.
    PubMed    


  78. SHELBAYA K, Claggett B, Dorbala P, Skali H, et al
    Stages of Valvular Heart Disease Among Older Adults in the Community: The Atherosclerosis Risk in Communities Study.
    Circulation. 2022 Dec 16. doi: 10.1161/CIRCULATIONAHA.122.061396.
    PubMed     Abstract available


  79. BERSELL KR, Yang T, Mosley JD, Glazer AM, et al
    Transcriptional Dysregulation Underlies Both Monogenic Arrhythmia Syndrome and Common Modifiers of Cardiac Repolarization.
    Circulation. 2022 Dec 16. doi: 10.1161/CIRCULATIONAHA.122.062193.
    PubMed     Abstract available


  80. MARK ESTES NA, Jain S, Saba S
    Coronary Vasospasm With Pulse Field Ablation: Primum Non Nocere.
    Circulation. 2022;146:1820-1822.
    PubMed    


  81. MARCUS GM
    Smartwatch-Detected Atrial Fibrillation: The "Value" in the Positive Predictive Value.
    Circulation. 2022;146:1733-1734.
    PubMed    


  82. BENZ AP, Eikelboom JW
    Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and End-Stage Renal Disease: Lessons Learned.
    Circulation. 2022;146:1746-1748.
    PubMed    


  83. THIAGARAJAN N, Ho WHH, Lim DYZ, Loo WTW, et al
    Yield of Cardiac Magnetic Resonance Imaging in a Preparticipation Cohort of Young Asian Males With T Wave Inversion.
    Circulation. 2022;146:1802-1804.
    PubMed    


    November 2022
  84. PRASAD P, Howell S, Sanghai S, Stecker E, et al
    Targeted Screening for Transthyretin Amyloid Cardiomyopathy in Patients With Atrial Fibrillation.
    Circulation. 2022;146:1730-1732.
    PubMed    


  85. VALDERRABANO M, Fuentes Rojas SC, Lador A, Patel A, et al
    Substrate Ablation by Multivein, Multiballoon Coronary Venous Ethanol for Refractory Ventricular Tachycardia in Structural Heart Disease.
    Circulation. 2022;146:1644-1656.
    PubMed     Abstract available


  86. PRYSTOWSKY EN
    Rate Versus Rhythm Control for Atrial Fibrillation: Has the Debate Been Settled?
    Circulation. 2022;146:1561-1563.
    PubMed    


  87. SCHINNER C, Xu L, Franz H, Zimmermann A, et al
    Defective Desmosomal Adhesion Causes Arrhythmogenic Cardiomyopathy by Involving an Integrin-alphaVbeta6/TGF-beta Signaling Cascade.
    Circulation. 2022;146:1610-1626.
    PubMed     Abstract available


  88. ZHANG S, Liu S, Leach JP, Li K, et al
    Gene Therapy Knockdown of Hippo Signaling Resolves Arrhythmic Events in Pigs After Myocardial Infarction.
    Circulation. 2022;146:1558-1560.
    PubMed    


  89. BRANDES A, Stavrakis S, Freedman B, Antoniou S, et al
    Consumer-Led Screening for Atrial Fibrillation: Frontier Review of the AF-SCREEN International Collaboration.
    Circulation. 2022;146:1461-1474.
    PubMed     Abstract available


  90. HAN J, Husband G, Doppalapudi H
    Tachycardia Associated With Pacing.
    Circulation. 2022;146:1475-1477.
    PubMed    


  91. KANAOKA K, Onoue K, Terasaki S, Nakano T, et al
    Features and Outcomes of Histologically Proven Myocarditis With Fulminant Presentation.
    Circulation. 2022;146:1425-1433.
    PubMed     Abstract available



  92. Correction to: Early Versus Delayed Non-Vitamin K Antagonist Oral Anticoagulant Therapy After Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based Randomized Controlled Noninferiority Study.
    Circulation. 2022;146:e279.
    PubMed    


  93. POKORNEY SD, Chertow GM, Al-Khalidi HR, Gallup D, et al
    Apixaban for Patients with Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial.
    Circulation. 2022 Nov 6. doi: 10.1161/CIRCULATIONAHA.121.054990.
    PubMed     Abstract available


  94. REINECKE H, Engelbertz C, Bauersachs R, Breithardt G, et al
    A Randomized Controlled Trial Comparing Apixaban to the Vitamin K-antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 study.
    Circulation. 2022 Nov 6. doi: 10.1161/CIRCULATIONAHA.122.062779.
    PubMed     Abstract available


    October 2022
  95. VISKIN S, Chorin E, Schwartz AL, Kukla P, et al
    Arrhythmogenic Effects of Cardiac Memory.
    Circulation. 2022;146:1170-1181.
    PubMed     Abstract available


  96. GASPERETTI A, Carrick RT, Costa S, Compagnucci P, et al
    Programmed Ventricular Stimulation as an Additional Primary Prevention Risk Stratification Tool in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multinational Study.
    Circulation. 2022 Oct 7:101161CIRCULATIONAHA122060866.
    PubMed     Abstract available


    September 2022
  97. PATTEN RD, Shah SP
    Addressing the Risk of Ventricular Arrhythmias and Sudden Death in Patients With Cardiac Sarcoidosis.
    Circulation. 2022;146:976-979.
    PubMed    



  98. Correction to: Association of Blood Pressure Classification Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Risk of Heart Failure and Atrial Fibrillation.
    Circulation. 2022;146:e186.
    PubMed    


  99. LUBITZ SA, Faranesh AZ, Selvaggi C, Atlas SJ, et al
    Detection of Atrial Fibrillation in a Large Population Using Wearable Devices: The Fitbit Heart Study.
    Circulation. 2022 Sep 23:101161CIRCULATIONAHA122060291.
    PubMed     Abstract available


  100. REDDY VY, Petru J, Funasako M, Kopriva K, et al
    Coronary Arterial Spasm During Pulsed Field Ablation to Treat Atrial Fibrillation.
    Circulation. 2022 Sep 22:101161CIRCULATIONAHA122061497.
    PubMed     Abstract available


  101. AL-KHATIB SM, Wojdyla DM, Granger CB, Wallentin L, et al
    Duration of Anticoagulation Interruption Before Invasive Procedures and Outcomes in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial.
    Circulation. 2022;146:958-960.
    PubMed    


  102. TSAI CF, Chuang YT, Chang KW
    A Peculiar Wide Complex Tachycardia During Flecainide Treatment.
    Circulation. 2022;146:955-957.
    PubMed    


  103. YANG E, Calkins H
    Who Benefits Most From Early Rhythm Control in Newly Diagnosed Atrial Fibrillation?
    Circulation. 2022;146:848-850.
    PubMed    


  104. OLDGREN J, Asberg S, Hijazi Z, Wester P, et al
    Early Versus Delayed Non-Vitamin K Antagonist Oral Anticoagulant Therapy After Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based Randomized Controlled Noninferiority Study.
    Circulation. 2022 Sep 6:101161CIRCULATIONAHA122060666.
    PubMed     Abstract available


    August 2022
  105. MEHRA R, Chung MK, Olshansky B, Dobrev D, et al
    Sleep-Disordered Breathing and Cardiac Arrhythmias in Adults: Mechanistic Insights and Clinical Implications: A Scientific Statement From the American Heart Association.
    Circulation. 2022;146:e119-e136.
    PubMed     Abstract available


  106. ZHAO Y, Riching AS, Knight WE, Chi C, et al
    Cardiomyocyte-Specific Long Noncoding RNA Regulates Alternative Splicing of the Triadin Gene in the Heart.
    Circulation. 2022;146:699-714.
    PubMed     Abstract available


  107. NORDENSWAN HK, Poyhonen P, Lehtonen J, Ekstrom K, et al
    Incidence of Sudden Cardiac Death and Life-Threatening Arrhythmias in Clinically Manifest Cardiac Sarcoidosis With and Without Current Indications for an Implantable Cardioverter Defibrillator.
    Circulation. 2022 Aug 24:101161CIRCULATIONAHA121058120.
    PubMed     Abstract available


  108. RADINOVIC A, Della Bella P
    Response by Radinovic and Della Bella to Letter Regarding Article, "Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial".
    Circulation. 2022;146:e71-e72.
    PubMed    


  109. BENALI K, Guenancia C, Martins RP
    Letter by Benali et al Regarding Article, "Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial".
    Circulation. 2022;146:e69-e70.
    PubMed    


  110. RILLIG A, Borof K, Breithardt G, Camm AJ, et al
    Early Rhythm Control in Patients With Atrial Fibrillation and High Comorbidity Burden.
    Circulation. 2022 Aug 15:101161CIRCULATIONAHA122060274.
    PubMed     Abstract available


    July 2022
  111. VAN DER STUIJT W, Smeding L, Olde Nordkamp LRA, Knops RE, et al
    Response by van der Stuijt et al to Letter Regarding Article, "Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN Trial
    Circulation. 2022;146:e10-e11.
    PubMed    


  112. MADIAS C, Madias JE
    Letter by Madias and Madias Regarding Article, "Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN Trial".
    Circulation. 2022;146:e8-e9.
    PubMed    


  113. REDDY YNV, Borlaug BA, Gersh BJ
    Management of Atrial Fibrillation Across the Spectrum of Heart Failure With Preserved and Reduced Ejection Fraction.
    Circulation. 2022;146:339-357.
    PubMed     Abstract available


  114. ESSIEN UR, Johnson AE
    Whose Streets? Neighborhood-Level Determinants of Atrial Fibrillation Care.
    Circulation. 2022;146:172-174.
    PubMed    


  115. SHAH RA, Asatryan B, Sharaf Dabbagh G, Aung N, et al
    Frequency, Penetrance, and Variable Expressivity of Dilated Cardiomyopathy-Associated Putative Pathogenic Gene Variants in UK Biobank Participants.
    Circulation. 2022;146:110-124.
    PubMed     Abstract available


  116. TONG D, Schiattarella GG, Jiang N, Daou D, et al
    Impaired AMP-Activated Protein Kinase Signaling in Heart Failure With Preserved Ejection Fraction-Associated Atrial Fibrillation.
    Circulation. 2022;146:73-76.
    PubMed    


    June 2022
  117. AVENDANO R, Lavi N, Rosenfeld LE
    Around and Around...A Wide Complex Tachycardia.
    Circulation. 2022;145:1867-1869.
    PubMed    


  118. KANAGASUNDRAM AN, Richardson TD, Stevenson WG
    Can Early Ablation of Ventricular Tachycardia Improve Survival?
    Circulation. 2022;145:1850-1852.
    PubMed    


  119. TUNG R, Xue Y, Chen M, Jiang C, et al
    First-Line Catheter Ablation of Monomorphic Ventricular Tachycardia in Cardiomyopathy Concurrent With Defibrillator Implantation: The PAUSE-SCD Randomized Trial.
    Circulation. 2022;145:1839-1849.
    PubMed     Abstract available


  120. CHEW DS, Li Y, Cowper PA, Anstrom KJ, et al
    Cost-Effectiveness of Catheter Ablation Versus Antiarrhythmic Drug Therapy in Atrial Fibrillation: The CABANA Randomized Clinical Trial.
    Circulation. 2022 Jun 21:101161CIRCULATIONAHA122058575.
    PubMed     Abstract available


  121. MORGAN E, Anderson J, Noheria A
    Premature Complexes and Blocked P Wave.
    Circulation. 2022;145:1803-1805.
    PubMed    


  122. ABDEL-QADIR H, Akioyamen LE, Fang J, Pang A, et al
    Association of Neighborhood-Level Material Deprivation With Atrial Fibrillation Care in a Single-Payer Health Care System: A Population-Based Cohort Study.
    Circulation. 2022 Jun 9:101161CIRCULATIONAHA122058949.
    PubMed     Abstract available


  123. POKORNEY SD, Granger CB
    Evidence Builds for Catheter Ablation for Atrial Fibrillation and Heart Failure.
    Circulation. 2022;145:1705-1707.
    PubMed    


    May 2022
  124. MAQSOOD N, Cooper JM, Whitman IR
    Letter by Maqsood et al Regarding Article, "Anterior-Lateral Versus Anterior-Posterior Electrode Position for Cardioverting Atrial Fibrillation".
    Circulation. 2022;145:e1054-e1055.
    PubMed    


  125. IBRAHIM OA, Belley-Cote EP, McIntyre WF
    Letter by Ibrahim et al Regarding Article, "Anterior-Lateral Versus Anterior-Posterior Electrode Position for Cardioverting Atrial Fibrillation".
    Circulation. 2022;145:e1056.
    PubMed    


  126. SCHMIDT AS, Lauridsen KG, Albertsen AE, Lofgren B, et al
    Response to Letters Regarding Article, "Anterior-Lateral Versus Anterior-Posterior Electrode Position for Cardioverting Atrial Fibrillation".
    Circulation. 2022;145:e1057-e1058.
    PubMed    


  127. NAUFFAL V, Morrill VN, Jurgens SJ, Choi SH, et al
    Monogenic and Polygenic Contributions to QTc Prolongation in the Population.
    Circulation. 2022;145:1524-1533.
    PubMed     Abstract available


  128. VAN OPBERGEN CJM, Bagwan N, Maurya SR, Kim JC, et al
    Exercise Causes Arrhythmogenic Remodeling of Intracellular Calcium Dynamics in Plakophilin-2-Deficient Hearts.
    Circulation. 2022;145:1480-1496.
    PubMed     Abstract available


  129. GROENEVELD SA, van der Ree MH, Mulder BA, Balt J, et al
    Prevalence of Short-Coupled Ventricular Fibrillation in a Large Cohort of Dutch Patients With Idiopathic Ventricular Fibrillation.
    Circulation. 2022;145:1437-1439.
    PubMed    


    April 2022
  130. NATALE A, Kar S, Holmes D
    Letter by Natale et al Regarding Article, "Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial".
    Circulation. 2022;145:e847-e848.
    PubMed    


  131. PRICE MJ, Gibson DN, Kar S
    Letter by Price et al Regarding the Article, "Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial".
    Circulation. 2022;145:e849.
    PubMed    


  132. DHRUVA SS, Redberg RF
    Letter by Dhruva and Redberg Regarding Article, "Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial".
    Circulation. 2022;145:e845-e846.
    PubMed    


  133. HOCHSTADT A, Rosso R, Viskin S
    Sinus Node Dysfunction With a Nice Twist.
    Circulation. 2022;145:1285-1287.
    PubMed    



  134. Correction to: Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International Collaboration.
    Circulation. 2022;145:e842.
    PubMed    


  135. FATKIN D, Cox CD, Martinac B
    Fishing for Links Between Omega-3 Fatty Acids and Atrial Fibrillation.
    Circulation. 2022;145:1037-1039.
    PubMed    


  136. DELLA BELLA P, Baratto F, Vergara P, Bertocchi P, et al
    Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial.
    Circulation. 2022 Apr 3. doi: 10.1161/CIRCULATIONAHA.122.059598.
    PubMed     Abstract available


    March 2022
  137. EXTRAMIANA F, Steg PG
    Atrial Fibrillation Screening: The Tools Are Ready, But Should We Do It?
    Circulation. 2022;145:955-958.
    PubMed    


  138. MUGNAI G, Gambaro A, Ribichini FL
    A Tachycardia in Disguise.
    Circulation. 2022;145:1024-1028.
    PubMed    


  139. PARKASH R, Wells GA, Rouleau J, Talajic M, et al
    Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients with Heart Failure and Atrial Fibrillation: Results from the RAFT-AF trial.
    Circulation. 2022 Mar 22. doi: 10.1161/CIRCULATIONAHA.121.057095.
    PubMed     Abstract available


  140. WALSH R, Bezzina C, Wilde AAM
    First Steps of Population Genomic Medicine in the Arrhythmia World: Pros and Cons.
    Circulation. 2022;145:892-895.
    PubMed    


  141. GLAZER AM, Davogustto G, Shaffer CM, Vanoye CG, et al
    Arrhythmia Variant Associations and Reclassifications in the eMERGE-III Sequencing Study.
    Circulation. 2022;145:877-891.
    PubMed     Abstract available


  142. ANDRADE JG, Macle L
    Atrial Fibrillation Ablation: Aiming to Improve Quantity and Quality of Life.
    Circulation. 2022;145:805-807.
    PubMed    


  143. TANG Y, Zhang Y, Yang XY
    Rare Case of Wide QRS Tachycardia After Sintilimab Treatment for Lung Cancer.
    Circulation. 2022;145:783-786.
    PubMed    


  144. KOWALEWSKI C, Dagres N, Hindricks G
    Are 2 Left Atrial Appendage Guards Better Than 1? The Amulet IDE Randomized Trial.
    Circulation. 2022;145:739-741.
    PubMed    


  145. BOAS R, Sappler N, von Stulpnagel L, Klemm M, et al
    Periodic Repolarization Dynamics Identifies ICD Responders in Nonischemic Cardiomyopathy: A DANISH Substudy.
    Circulation. 2022;145:754-764.
    PubMed     Abstract available


  146. GALEA R, De Marco F, Meneveau N, Aminian A, et al
    Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical Trial.
    Circulation. 2022;145:724-738.
    PubMed     Abstract available


  147. LUBITZ SA, Atlas SJ, Ashburner JM, Trisini Lipsanopoulos AT, et al
    Screening for Atrial Fibrillation in Older Adults at Primary Care Visits: the VITAL-AF Randomized Controlled Trial.
    Circulation. 2022 Mar 2. doi: 10.1161/CIRCULATIONAHA.121.057014.
    PubMed     Abstract available


  148. YOSHIDA T, Nakamura A, Funada J, Amino M, et al
    Efficacy and Safety of Edoxaban 15 mg According to Renal Function in Very Elderly Patients With Atrial Fibrillation: A Subanalysis of the ELDERCARE-AF Trial.
    Circulation. 2022;145:718-720.
    PubMed    


    February 2022

  149. Correction to: Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex.
    Circulation. 2022;145:e640.
    PubMed    


  150. VAN OUWERKERK AF, Bosada FM, van Duijvenboden K, Houweling AC, et al
    Patient-Specific TBX5-G125R Variant Induces Profound Transcriptional Deregulation and Atrial Dysfunction.
    Circulation. 2022;145:606-619.
    PubMed     Abstract available


  151. HAUSLER KG, Eichner FA, Heuschmann PU, Fiebach JB, et al
    MRI-Detected Brain Lesions and Cognitive Function in Atrial Fibrillation Patients Undergoing Left Atrial Catheter Ablation in the Randomized AXAFA-AFNET 5 Trial.
    Circulation. 2022 Feb 9. doi: 10.1161/CIRCULATIONAHA.121.056320.
    PubMed     Abstract available


  152. RIVARD L, Friberg L, Conen D, Healey JS, et al
    Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International Collaboration.
    Circulation. 2022;145:392-409.
    PubMed     Abstract available


  153. PELTENBURG PJ, Kallas D, Bos JM, Lieve KVV, et al
    An International Multicenter Cohort Study on beta-Blockers for the Treatment of Symptomatic Children With Catecholaminergic Polymorphic Ventricular Tachycardia.
    Circulation. 2022;145:333-344.
    PubMed     Abstract available


  154. KNOPS RE, van der Stuijt W, Delnoy PPHM, Boersma LVA, et al
    Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN Trial.
    Circulation. 2022;145:321-329.
    PubMed     Abstract available


    January 2022
  155. GOTO S, Goto S
    A Patient-Level Meta-Analysis: The End of the Era of Direct Oral Anticoagulant Developmental Trials in Patients With Atrial Fibrillation?
    Circulation. 2022;145:256-258.
    PubMed    


  156. WADA Y, Yang T, Shaffer CM, Daniel LL, et al
    Common Ancestry-Specific Ion Channel Variants Predispose to Drug-Induced Arrhythmias.
    Circulation. 2022;145:299-308.
    PubMed     Abstract available


  157. CARNICELLI AP, Hong H, Connolly SJ, Eikelboom J, et al
    Direct Oral Anticoagulants versus Warfarin in Patients with Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials with Interaction Testing by Age and Sex.
    Circulation. 2022 Jan 5. doi: 10.1161/CIRCULATIONAHA.121.056355.
    PubMed     Abstract available


    December 2021
  158. BAHNSON TD, Giczewska A, Mark DB, Russo AM, et al
    Association Between Age and Outcomes of Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: Results from the CABANA Trial.
    Circulation. 2021 Dec 22. doi: 10.1161/CIRCULATIONAHA.121.055297.
    PubMed     Abstract available


  159. SAMUEL M, Nattel S
    Fish Oil Supplements May Increase the Risk for Atrial Fibrillation: What Does This Mean?
    Circulation. 2021;144:1991-1994.
    PubMed    


  160. MIRANDA-ARBOLEDA AF, Mohammad S, Baranchuk A
    Wide Complex Tachycardia and Syncope in the Emergency Department.
    Circulation. 2021;144:2040-2042.
    PubMed    


  161. STEINBERG C, Dognin N, Sodhi A, Champagne C, et al
    Driving Restrictions and Early Arrhythmias in Patients Receiving a Secondary Prevention Implantable Cardioverter-Defibrillator (DREAM-ICD-II study).
    Circulation. 2021 Dec 16. doi: 10.1161/CIRCULATIONAHA.121.056471.
    PubMed     Abstract available


  162. WARD-CAVINESS CK
    Accelerated Epigenetic Aging and Incident Atrial Fibrillation: New Outlook on an Immutable Risk Factor?
    Circulation. 2021;144:1912-1914.
    PubMed    


    November 2021
  163. HANKEY GJ
    Embolic Stroke of Undetermined Source: Can We Identify Subgroups With High Risk for Atrial Fibrillation Who May Benefit From Oral Anticoagulation?
    Circulation. 2021;144:1747-1749.
    PubMed    


  164. FINOCCHIARO G, Westaby J, Bhatia R, Malhotra A, et al
    Sudden Death in Female Athletes: Insights From a Large Regional Registry in the United Kingdom.
    Circulation. 2021;144:1827-1829.
    PubMed    


  165. SASMITA BR, Luo S, Huang B
    Wide and Narrow QRS Complex Tachycardia With Cycle Length Alternans: What Is the Mechanism?
    Circulation. 2021;144:1824-1826.
    PubMed    


  166. AGUILAR M, Macle L, Deyell MW, Yao R, et al
    The Influence of Monitoring Strategy on Assessment of Ablation Success and Post-ablation Atrial Fibrillation Burden Assessment: Implications for Practice and Clinical Trial Design.
    Circulation. 2021 Nov 24. doi: 10.1161/CIRCULATIONAHA.121.056109.
    PubMed     Abstract available


  167. SCHMIDT AS, Lauridsen KG, Moller DS, Christensen PD, et al
    Anterior-Lateral Versus Anterior-Posterior Electrode Position for Cardioverting Atrial Fibrillation.
    Circulation. 2021 Nov 24. doi: 10.1161/CIRCULATIONAHA.121.056301.
    PubMed     Abstract available


  168. BERTERO E, Nickel A, Kohlhaas M, Hohl M, et al
    Loss of Mitochondrial Ca(2+) Uniporter Limits Inotropic Reserve and Provides Trigger and Substrate for Arrhythmias in Barth Syndrome Cardiomyopathy.
    Circulation. 2021;144:1694-1713.
    PubMed     Abstract available


  169. KIRCHHOF P
    In Patients With Recently Diagnosed Atrial Fibrillation, Think Anticoagulation and Rhythm Control.
    Circulation. 2021;144:1587-1589.
    PubMed    


  170. KHURSHID S, Friedman S, Reeder C, Di Achille P, et al
    Electrocardiogram-based Deep Learning and Clinical Risk Factors to Predict Atrial Fibrillation.
    Circulation. 2021 Nov 8. doi: 10.1161/CIRCULATIONAHA.121.057480.
    PubMed     Abstract available


  171. ROMANI F, Monasky MM, Pappone C
    Letter by Romani et al Regarding Article, "Extracellular Vesicles From Epicardial Fat Facilitate Atrial Fibrillation".
    Circulation. 2021;144:e280-e281.
    PubMed    


  172. LEOR J, Ram E, Naftali-Shani N, Shaihov-Teper O, et al
    Response by Leor et al to Letter Regarding Article, "Extracellular Vesicles From Epicardial Fat Facilitate Atrial Fibrillation".
    Circulation. 2021;144:e282.
    PubMed    


    October 2021
  173. YAZAKI Y, Nakamura M, Iijima R, Yasuda S, et al
    Clinical Outcomes of Rivaroxaban Monotherapy in Heart Failure Patients With Atrial Fibrillation and Stable Coronary Disease: Insights From the AFIRE Trial.
    Circulation. 2021;144:1449-1451.
    PubMed    


  174. BELHASSEN B, Shauer A, Biton Y
    Left Bundle-Branch Block Tachycardia After Transcatheter Aortic Valve Replacement.
    Circulation. 2021;144:1444-1448.
    PubMed    


  175. BAHIT MC, Sacco RL, Easton JD, Meyerhoff J, et al
    Predictors of Development of Atrial Fibrillation in Patients With Embolic Stroke Of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial.
    Circulation. 2021 Oct 15. doi: 10.1161/CIRCULATIONAHA.121.055176.
    PubMed     Abstract available


  176. HIGUCHI S, Goldschlager N, Gerstenfeld EP
    Atrioventricular Block With Narrow and Wide QRS: The Pause That Refreshes.
    Circulation. 2021;144:1262-1264.
    PubMed    


  177. GENCER B, Djousse L, Al-Ramady OT, Cook NR, et al
    Effect of Long-Term Marine Omega-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.
    Circulation. 2021 Oct 6. doi: 10.1161/CIRCULATIONAHA.121.055654.
    PubMed     Abstract available


    September 2021
  178. ROBERTS JD, Vittinghoff E, Lu AT, Alonso A, et al
    Epigenetic Age and the Risk of Incident Atrial Fibrillation.
    Circulation. 2021 Sep 30. doi: 10.1161/CIRCULATIONAHA.121.056456.
    PubMed     Abstract available


  179. HULSURKAR MM, Lahiri SK, Moore O, Moreira LM, et al
    Atrial-Specific LKB1 Knockdown Represents a Novel Mouse Model of Atrial Cardiomyopathy With Spontaneous Atrial Fibrillation.
    Circulation. 2021;144:909-912.
    PubMed    


  180. VISKIN S, Chorin E, Viskin D, Hochstadt A, et al
    Polymorphic Ventricular Tachycardia: Terminology, Mechanism, Diagnosis, and Emergency Therapy.
    Circulation. 2021;144:823-839.
    PubMed     Abstract available


  181. SUN Z, Wang L, Han L, Wang Y, et al
    Functional Calsequestrin-1 Is Expressed in the Heart and Its Deficiency Is Causally Related to Malignant Hyperthermia-Like Arrhythmia.
    Circulation. 2021;144:788-804.
    PubMed     Abstract available


    August 2021
  182. MACHEREY S, Sinning JM, Mauri V
    Wide QRS Complex Bradycardia in a Hemodynamically Unstable Young Woman.
    Circulation. 2021;144:659-661.
    PubMed    


  183. AN ZY, Peng D, Shi YJ
    A Patient With Acute Shortness of Breath and Inferior ST-Segment Elevation: A Diagnostic Trap.
    Circulation. 2021;144:577-579.
    PubMed    


  184. RAAD N, Bittihn P, Cacheux M, Jeong D, et al
    Arrhythmia Mechanism and Dynamics in a Humanized Mouse Model of Inherited Cardiomyopathy Caused by Phospholamban R14del Mutation.
    Circulation. 2021;144:441-454.
    PubMed     Abstract available


  185. CHEANG S, LeLorier P, Gajewski K
    Diffuse ST-Segment Elevation With Idiopathic Malignant Ventricular Arrhythmia.
    Circulation. 2021;144:399-402.
    PubMed    


    July 2021
  186. RILLIG A, Magnussen C, Ozga AK, Suling A, et al
    Early Rhythm Control Therapy in Patients with Atrial Fibrillation and Heart Failure.
    Circulation. 2021 Jul 30. doi: 10.1161/CIRCULATIONAHA.121.056323.
    PubMed     Abstract available


  187. REAL C, Morales T, Viana-Tejedor A
    An Unusual Call From the Urology Ward.
    Circulation. 2021;144:324-327.
    PubMed    


  188. FRADLEY MG, Beckie TM, Brown SA, Cheng RK, et al
    Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A Scientific Statement From the American Heart Association.
    Circulation. 2021;144:e41-e55.
    PubMed     Abstract available


  189. FELKER GM, Butler J, Ibrahim NE, Pina IL, et al
    Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF.
    Circulation. 2021;144:180-182.
    PubMed    


  190. VISKIN S, Marai I, Rosso R
    Long QT Syndrome and Torsade de Pointes Ultimately Treated With Quinidine: Introducing the Concept of Pseudo-Torsade de Pointes.
    Circulation. 2021;144:85-89.
    PubMed    


    June 2021
  191. PASSMAN R
    "Pill-in-Pocket" Anticoagulation for Atrial Fibrillation: Fiction, Fact, or Foolish?
    Circulation. 2021;143:2211-2213.
    PubMed    


  192. BHASIN D, Kumar R, Gupta A
    A Young Woman With Palpitations: A Poison or a Remedy?
    Circulation. 2021;143:2312-2315.
    PubMed    


  193. BOULET J, Massie E, Liszkowski M
    A Silent Arrhythmia: How Would You Manage This Patient?
    Circulation. 2021;143:2205-2207.
    PubMed    


    May 2021
  194. SINGH M, Joglar J
    Morbidly Obese Patients With Symptomatic Atrial Fibrillation: Why Are We Holding Back on Bariatric Surgery?
    Circulation. 2021;143:1838-1840.
    PubMed    


  195. WALDMANN V, Combes N, Narayanan K, Marijon E, et al
    Response by Waldmann et al to Letter Regarding Article, "Long-Term Follow-Up of Patients With Tetralogy of Fallot and Implantable Cardioverter Defibrillator: The DAI-T4F Nationwide Registry".
    Circulation. 2021;143:e900-e901.
    PubMed    


  196. FERRERO P, Chessa M
    Letter by Ferrero and Chessa Regarding Article, "Long-Term Follow-Up of Patients With Tetralogy of Fallot and Implantable Cardioverter Defibrillator: The DAI-T4F Nationwide Registry".
    Circulation. 2021;143:e898-e899.
    PubMed    


    April 2021
  197. GILLIS AM, Wilton SB
    Rhythm Control of Atrial Fibrillation: The Earlier the Better?
    Circulation. 2021;143:1639-1641.
    PubMed    


  198. KANEKO H, Yano Y, Itoh H, Morita K, et al
    Association of Blood Pressure Classification Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline with Risk of Heart Failure and Atrial Fibrillation.
    Circulation. 2021 Apr 22. doi: 10.1161/CIRCULATIONAHA.120.052624.
    PubMed     Abstract available


  199. RANSOM JL, Wong KC
    Palpitations in the Clinic.
    Circulation. 2021;143:1631-1634.
    PubMed    


  200. BENZ AP, Hijazi Z, Lindback J, Connolly SJ, et al
    Biomarker-Based Risk Prediction With The ABC-AF Scores in Patients With Atrial Fibrillation Not Receiving Oral Anticoagulation.
    Circulation. 2021 Apr 14. doi: 10.1161/CIRCULATIONAHA.120.053100.
    PubMed     Abstract available


  201. DAI XC, An ZY
    Severe Arrhythmia Caused by a Chinese Herb Liquor: What Is the Diagnosis?
    Circulation. 2021;143:1450-1451.
    PubMed    


    March 2021
  202. GIUDICESSI JR, Schram M, Bos JM, Galloway CD, et al
    Artificial Intelligence-Enabled Assessment of the Heart Rate Corrected QT Interval Using a Mobile Electrocardiogram Device.
    Circulation. 2021;143:1274-1286.
    PubMed     Abstract available


  203. ROSENBERG MA
    Trusting Magic: Interpretability of Predictions From Machine Learning Algorithms.
    Circulation. 2021;143:1299-1301.
    PubMed    


  204. PENG D, Liu X, Pan Y
    Irregular Complex Tachycardia: Not Dual Atrioventricular Nodal Nonreentrant Tachycardia.
    Circulation. 2021;143:1173-1176.
    PubMed    


  205. CONSTANT DIT BEAUFILS AL, Huttin O, Jobbe-Duval A, Senage T, et al
    Replacement Myocardial Fibrosis in Patients with Mitral Valve Prolapse: Relation to Mitral Regurgitation, Ventricular Remodeling and Arrhythmia.
    Circulation. 2021 Mar 12. doi: 10.1161/CIRCULATIONAHA.120.050214.
    PubMed     Abstract available


  206. PILLAI A, Ellenbogen KA, Padala SK
    A Tale of 2 Blocks.
    Circulation. 2021;143:1062-1065.
    PubMed    


    February 2021
  207. ARAS D, Ozeke O, Topaloglu S
    When You Hear Hoofbeats, Look for Horses, Not Zebras.
    Circulation. 2021;143:862-864.
    PubMed    


  208. WORKMAN V, Forrest JK, Enriquez A
    A Case of Presyncope After Transcatheter Aortic Valve Replacement.
    Circulation. 2021;143:857-861.
    PubMed    


  209. YAMAGUCHI N, Xiao J, Narke D, Shaheen D, et al
    Cardiac Pressure Overload Decreases ETV1 Expression in the Left Atrium, Contributing to Atrial Electrical and Structural Remodeling.
    Circulation. 2021;143:805-820.
    PubMed     Abstract available


  210. KARABINOS I, Kostaki P, Panagopoulos Z
    Bizarre Downsloping ST Segment Elevation Challenge.
    Circulation. 2021;143:599-601.
    PubMed    


  211. CHEN AY, Nishimura T, Tung R
    Narrowing the Differential Diagnosis for a Wide Complex Tachycardia.
    Circulation. 2021;143:503-506.
    PubMed    


    January 2021
  212. TOMCSANYI J, Paulik R, Fresz T
    Acute Coronary Syndrome With Tall R Waves and Inverted T Waves in the Precordial Leads: An Ignored Entity.
    Circulation. 2021;143:397-400.
    PubMed    


  213. KANAGASUNDRAM AN, Richardson TD, Stevenson WG
    The Heart Rate of Ventricular Tachycardia.
    Circulation. 2021;143:227-229.
    PubMed    


  214. NISHIMURA T, Upadhyay GA, Aziz ZA, Beaser AD, et al
    Circuit Determinants of Ventricular Tachycardia Cycle Length: Characterization of Fast and Unstable Human Ventricular Tachycardia.
    Circulation. 2021;143:212-226.
    PubMed     Abstract available


  215. GOLD MR, Lambiase PD, El-Chami MF, Knops RE, et al
    Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial.
    Circulation. 2021;143:7-17.
    PubMed     Abstract available


    December 2020
  216. PAL N, Padala S, Klein K
    Letter by Pal et al Regarding Article, "Impact of Left Atrial Appendage Exclusion on Short-Term Outcomes in Isolated Coronary Artery Bypass Graft Surgery".
    Circulation. 2020;142:e501-e502.
    PubMed    


  217. BELLEY-COTE EP, Whitlock RP
    Letter by Belley-Cote and Whitlock Regarding Article, "Impact of Left Atrial Appendage Exclusion on Short-Term Outcomes in Isolated Coronary Artery Bypass Graft Surgery".
    Circulation. 2020;142:e503.
    PubMed    


  218. MAHMOOD E, Sharkey A, Matyal R, Mahmood F, et al
    Response by Mahmood et al to Letter Regarding Article, "Impact of Left Atrial Appendage Exclusion on Short-Term Outcomes in Isolated Coronary Artery Bypass Graft Surgery".
    Circulation. 2020;142:e504-e505.
    PubMed    


    October 2020
  219. MACONOCHIE IK, Aickin R, Hazinski MF, Atkins DL, et al
    Pediatric Life Support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
    Circulation. 2020;142.
    PubMed     Abstract available


  220. BERG KM, Soar J, Andersen LW, Bottiger BW, et al
    Adult Advanced Life Support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
    Circulation. 2020;142.
    PubMed     Abstract available


    June 2020
  221. MAHMOOD E, Matyal R, Mahmood F, Xu X, et al
    Impact of Left Atrial Appendage Exclusion on Short Term Outcomes In Isolated Coronary Artery Bypass Graft Surgery.
    Circulation. 2020 Jun 3. doi: 10.1161/CIRCULATIONAHA.119.044642.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.